| BK polyomavirus: clinical aspects, immune regulation, and emerging therapies GR Ambalathingal, RS Francis, MJ Smyth, C Smith, R Khanna Clinical microbiology reviews 30 (2), 503-528, 2017 | 252 | 2017 |
| Biofilm inhibitory effect of silver nanoparticles coated catheter against Staphylococcus aureus and evaluation of its synergistic effects with antibiotics SKR Namasivayam, M Preethi, A Bharani, G Robin, B Latha Int J Biol Pharm Res 3 (2), 259-265, 2012 | 51 | 2012 |
| Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme C Smith, KE Lineburg, JP Martins, GR Ambalathingal, MA Neller, ... The Journal of clinical investigation 130 (11), 6041-6053, 2020 | 50 | 2020 |
| Rapid detection of SARS‐CoV‐2‐specific memory T‐cell immunity in recovered COVID‐19 cases KE Lineburg, S Srihari, M Altaf, S Swaminathan, A Panikkar, J Raju, ... Clinical & Translational Immunology 9 (12), e1219, 2020 | 25 | 2020 |
| Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice V Dasari, LK McNeil, K Beckett, M Solomon, G Ambalathingal, TL Thuy, ... Nature Communications 14 (1), 4371, 2023 | 24 | 2023 |
| 'Off-the-shelf’allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies D Sinha, S Srihari, K Beckett, L Le Texier, M Solomon, A Panikkar, ... Journal for ImmunoTherapy of Cancer 9 (2), 2021 | 22 | 2021 |
| SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants A Panikkar, KE Lineburg, J Raju, KY Chew, GR Ambalathingal, S Rehan, ... PloS Pathogens 18 (2), e1010339, 2022 | 20 | 2022 |
| T‐cell adoptive immunotherapy for BK nephropathy in renal transplantation S Jahan, C Scuderi, L Francis, MA Neller, S Rehan, P Crooks, ... Transplant Infectious Disease, e13399, 2020 | 19 | 2020 |
| Proteome‐wide analysis of T‐cell response to BK polyomavirus in healthy virus carriers and kidney transplant recipients reveals a unique transcriptional and functional profile GR Ambalathingal, RS Francis, D Corvino, S Srihari, BT Aftab, C Smith, ... Clinical & Translational Immunology 9 (1), e01102, 2020 | 17 | 2020 |
| Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients V Dasari, A Schuessler, C Smith, Y Wong, JJ Miles, MJ Smyth, ... Molecular Therapy Methods & Clinical Development 3, 2016 | 16 | 2016 |
| Rapid whole‐blood assay to detect SARS‐CoV‐2‐specific memory T‐cell immunity following a single dose of AstraZeneca ChAdOx1‐S COVID‐19 vaccine KE Lineburg, MA Neller, GR Ambalathingal, L Le Texier, J Raju, ... Clinical & Translational Immunology 10 (8), e1326, 2021 | 15 | 2021 |
| Preparation, optimization and characterization of biocompatible nanoalbumin-ofloxacin (BSANP-OF) conjugate and evaluation of control release, antibacterial activity against … SKR Namasivayam, ATG Robin Asian J Pharm Clin Res 6 (3), 235-9, 2013 | 14 | 2013 |
| Pretransplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: a prospective cohort study M Altaf, KE Lineburg, P Crooks, S Rehan, KK Matthews, MA Neller, ... The Journal of infectious diseases 224 (2), 312-317, 2021 | 13 | 2021 |
| Ablation of CD8+ T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3 S Swaminathan, KE Lineburg, A Panikkar, J Raju, LD Murdolo, C Szeto, ... Nature Communications 13 (1), 6387, 2022 | 10 | 2022 |
| A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice V Dasari, K Beckett, S Horsefield, G Ambalathingal, R Khanna PLoS Pathogens 18 (6), e1010403, 2022 | 9 | 2022 |
| Limited recognition of highly conserved regions of SARS-CoV-2 S Swaminathan, KE Lineburg, GR Ambalathingal, P Crooks, EJ Grant, ... Microbiology Spectrum 10 (1), e02780-21, 2022 | 8 | 2022 |
| Preparation of nano albumin-flutamide (Nab-flu) conjugate and evaluation of its in vitro drug control release, anticancer activity and genotoxicity S Namasivayam, AT Robin NISCAIR-CSIR, India, 2018 | 8 | 2018 |
| Optimal synthesis of biocompatible bovine serum nanoparticles-incorporated quercetin (BSA NPS-QT) nano drug conjugate for the controlled release and improved anti oxidative … SKR Namasivayam, L Raj, ATG Robin, JH Chandra, RSA Bharani Res. J. Pharm. Biol. Chem. Sci 5, 478-487, 2014 | 4 | 2014 |
| Recombination in sarbecovirus lineage and mutations/insertions in spike protein are linked to the emergence and adaptation of SARS-CoV-2 A Som, AK Sharma, P Kumari Bioinformation 18 (10), 951, 2022 | 3 | 2022 |
| Ablation of CD8+ T-cell recognition of an immunodominant epitope in SARS-CoV-2 omicron C Smith, S Swaminathan, K Lineburg, A Panikkar, J Raju, L Murdolo, ... | 2 | 2022 |
